Susquehanna Fundamental Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-551,224	Closed	-$1.68M	–	1262
2024 Q4	$1.68M	Buy	+551,224	New	+$2.4M	0.02%	575

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna Fundamental Investments's RVNC Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 551,224 shares — an estimated $1.68M sold.

Susquehanna Fundamental Investments first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $1.68M in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

Susquehanna Fundamental Investments reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 551,224 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $1.68M.
Susquehanna Fundamental Investments first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
Susquehanna Fundamental Investments's Revance Therapeutics, Inc. position peaked at $1.68M in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.